Newcastle Mater Misericordiae Hospital; Oncology

Waratah, New South Wales 2298

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy — Stopped early
• A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) — Completed